Origin Agritech Launches "Aoyun 2026" New Variety Promotion Program to Drive Commercialization of Next-Generation Seed Varieties

Origin Agritech (NASDAQ: SEED) launched the "Aoyun 2026" promotion program to accelerate commercialization of next-generation seed varieties ahead of China's spring planting season.

Rhea-AI Summary

Origin Agritech (NASDAQ: SEED) launched the "Aoyun 2026" promotion program to accelerate commercialization of next-generation seed varieties ahead of China's spring planting season.

The initiative centralizes national sales strategy, appoints Weiwei Shi as General Commander, coordinates subsidiary deployment across major corn belts, advances GMO and gene-editing commercialization via a strategic alliance, and formalizes 2026–2027 performance accountability contracts after a sales team rebuild.

Positive

• Sales team expanded from 63 to 106 professionals (fiscal 2025)
• Four new corn varieties launched in fiscal 2025 with multiple trial approvals
• Beijing seed production license secured for Beijing Origin
• Company-wide performance contracts signed for 2026–2027 to enforce accountability

Negative

• None.

Argus Mar 10 session

+0.88% close to close Open Argus

Details

News Market Reaction – SEED

On Mar 10, the day this news came out, SEED closed 0.88% above the previous close.

Data tracked by StockTitan Argus for the Mar 10 session.

Market Context

This announcement centers on the “Aoyun 2026” program, aligning Origin’s expanded 106-person sales f...

Analysis

This announcement centers on the “Aoyun 2026” program, aligning Origin’s expanded 106-person sales force, new corn varieties, and accountability contracts for 2026–2027 around a national commercialization push. It follows FY2025 results that showed RMB 91.3 million revenue and a RMB 53.3 million net loss. Investors may track execution on these sales goals, future use of the $30,000,000 shelf, and progress in GMO and gene-editing commercialization.

Key Figures

FY2025 revenue: RMB 91.3 million (US$12.8M) FY2025 net loss: RMB 53.3 million (US$7.5M) Cash balance: RMB 15.9 million +5 more

FY2025 revenue

RMB 91.3 million (US$12.8M)

Fiscal year ended September 30, 2025

FY2025 net loss

RMB 53.3 million (US$7.5M)

Attributable to Origin shareholders in FY2025

Cash balance

RMB 15.9 million

End of fiscal year 2025

Private placement size

2,000,000 shares at US$1.40

Executed via Securities Purchase Agreements for up to US$2,800,000

Gross proceeds (placement)

US$2,800,000

Projected from February 1, 2026 private placement

Shelf registration amount

$30,000,000

Form F-3 shelf registered for ordinary shares, warrants, and units

Price move pre-news

9.62%

Change over the prior 24 hours to <b>$1.14</b>

Sales team expansion

63 to 106 professionals

Growth during fiscal year 2025

Historical Context

5 past events · Latest: Jan 30

5 events

1. Jan 30

   Fiscal 2025 earnings

   24h Move

   -7.7%

   Reported lower revenue and a net loss driven by Xinjiang factory upgrades.

2. Jan 26

   Earnings call notice

   24h Move

   -3.1%

   Announced timing and details of FY2025 results call and 20-F filing.

3. Dec 22

   R&D strategy meeting

   24h Move

   +0.8%

   Outlined 2026 priorities in AI-integrated breeding and market expansion initiatives.

4. Dec 02

   Hi3 tech recognition

   24h Move

   -3.7%

   Hi3 gene-editing system named Top 10 agricultural science progress for 2025.

5. Nov 10

   Gene-editing license

   24h Move

   -2.8%

   Licensed Cas-SF01 platform and advanced smart-architecture gene-edited corn lines.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Key Terms

germplasm, gmo, gene-editing technologies

3 terms

germplasm medical

"Origin's research pipeline is stocked with competitive germplasm, and commercialization..."

Germplasm is the living genetic material—seeds, tissue, or cells—used to preserve and breed plants or animals. Think of it as a library or toolbox of traits (like drought tolerance or disease resistance) that breeders and biotech firms draw from to create new varieties. For investors, germplasm represents durable intellectual property and a source of future revenue and risk reduction because it underpins crop improvement, product differentiation, and resilience to changing markets and climates.

gmo medical

"...commercialization of GMO and gene-editing technologies is being accelerated through..."

A genetically modified organism (GMO) is a plant, animal or microbe whose genetic material has been intentionally changed using laboratory techniques to add, remove or alter specific traits. Investors care because GMOs can change crop yields, costs, regulatory risk and market acceptance—much like upgrading parts in a car can improve performance but may also affect warranty and resale value—so their use can materially affect a company’s profitability and reputation.

gene-editing technologies medical

"...commercialization of GMO and gene-editing technologies is being accelerated..."

Gene-editing technologies are laboratory methods that change an organism’s DNA to add, remove, or alter specific genes, like using precise molecular scissors to cut and rewrite genetic code. Investors watch them because they can enable new treatments, diagnostics, or crop improvements, influence development speed and costs, and affect regulatory and safety risks—factors that shape a biotech or agritech company’s potential value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Company Aligns National Sales Strategy and Performance Accountability to Accelerate Market Penetration Ahead of Spring Planting Season

BEIJING, March 10, 2026 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced the official launch of its "Aoyun 2026" new variety promotion program, a major commercial initiative designed to accelerate the market adoption of its latest high-performing seed products. The formal launch was held at the conclusion of its 2026 Annual Marketing Executive Conference, held March 2–3, 2026 in Changsha, Hunan Province.

The Aoyun 2026 project is a core commercial vehicle for advancing newer varieties into broader planting markets in 2026. Weiwei Shi, General Manager of Henan Origin, was appointed as General Commander of the Aoyun 2026 project. The program will be executed in coordination with all of Origin's subsidiary companies, with the stated objective of driving higher value for growers through next-generation seed varieties.

The launch is consistent with the product pipeline priorities the Company has established heading into the 2026 selling season. Origin's research pipeline is stocked with competitive germplasm, and commercialization of GMO and gene-editing technologies is being accelerated through Origin's strategic alliance with China Golden-mark Biotech. During fiscal year 2025, Origin launched four new corn varieties — Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728 — with multiple national and provincial trial approvals received.

National Regional Deployment Plans Finalized

Also taking place during the conference, regional teams from Henan, Shandong, Anhui, Jiangsu, Hubei, the Northeast provinces, and Xinjiang each presented and finalized their respective annual campaign plans. The collective deployment spans Origin's primary target markets, covering the Huanghuai Hai corn belt, the Northeast four-province corn corridor, and markets in central and northwest China.

The regional rollout timing aligns with China's spring planting season, which officially began after Jingzhe — the traditional solar term marking the reawakening of the agricultural cycle — on March 5, 2026.

The conference also included substantive discussion of Origin's online and offline channel integration strategy, with specific attention to the operating model of the Company's "Golden Harvest Club" distributor alliance — a strategic initiative Origin launched in fiscal year 2025 to strengthen relationships across its distribution ecosystem.

Performance Accountability Contracts Signed for 2026–2027

A central focus of the conference was the formal signing of performance accountability contracts covering fiscal years 2026 and 2027. Origin CEO Weibin Yan and Vice President Yubiao Liu signed contracts with the Company's core management team and subsidiary general managers, committing each unit to specific operational and financial targets. Vice President and Marketing Director Jing Dou subsequently signed individual agreements with each subsidiary general manager, establishing clear accountability chains across Origin's distribution and sales organization.

The contract-signing process formalizes accountability structures across Origin's commercial organization following a year of significant rebuilding. During fiscal year 2025, the Company expanded its sales team from 63 to 106 professionals, completed leadership restructuring, and secured Beijing Origin's seed production operation license. The performance contracts are designed to convert that rebuilt infrastructure into measurable commercial results in the seasons ahead.

Management Commentary

"The launch of 'Aoyun 2026' represents a pivotal moment for Origin Agritech, marking our transition from a period of rebuilding to a new era of aggressive commercial execution," said Weibin Yan, CEO of Origin Agritech. "We have spent the last year meticulously assembling the core assets for success: a world-class sales organization, a product pipeline stocked with elite germplasm, and a disciplined accountability framework that aligns the entire company around a single goal — market penetration. 'Aoyun 2026' is the engine that will convert these assets into tangible shareholder value. We are providing our growers with the next-generation technology they need to thrive, and in doing so, we are positioning Origin to capture market share in the seasons ahead."

About Origin Agritech Limited

Origin Agritech Limited, founded in 1997 and headquartered in Origin R&D Center, Songzhuang, Tongzhou in Beijing, is a leading Chinese agricultural technology company. In crop seed biotechnologies, Origin Agritech's phytase corn was the first transgenic corn to receive the Bio-Safety Certificate from China's Ministry of Agriculture. Over the years, Origin has established a robust biotechnology seed pipeline, including products with glyphosate tolerance and pest resistance (Bt) traits. For further information, please visit the Company's website at www.originagritech.com. The Company also maintains an X account for updating investors on Company and industry developments which is https://x.com/origin_agritech.

For more information, please contact:
Origin Agritech Limited Contact:
Kate Lang (Mandarin/English)
Director of Investor Relations
Phone: +86 186-1839-3368
Email: bing.lang@originseed.com.cn

Investor Relations Contact:
Matthew Abenante, IRC
President
Strategic Investor Relations, LLC
Tel: 347-947-2093
Email: matthew@strategic-ir.com

View original content:https://www.prnewswire.com/news-releases/origin-agritech-launches-aoyun-2026-new-variety-promotion-program-to-drive-commercialization-of-next-generation-seed-varieties-302708797.html

SOURCE Origin Agritech Limited

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is Origin Agritech's Aoyun 2026 program and how will it affect SEED sales?

Aoyun 2026 is a national promotion program to accelerate commercialization of new seed varieties. According to the company, it coordinates subsidiary rollouts, regional deployment plans across major corn belts, and channel integration to drive market penetration during the 2026 planting season.

Which new corn varieties did Origin Agritech introduce before Aoyun 2026 (SEED)?

Origin launched four new corn varieties in fiscal 2025: Jingke 317, Jinqiao 8, Xundan 203, and Aoyu 728. According to the company, these varieties received multiple national and provincial trial approvals ahead of the 2026 commercialization push.

Who leads the Aoyun 2026 initiative at Origin Agritech (SEED)?

Weiwei Shi, General Manager of Henan Origin, was appointed General Commander of Aoyun 2026. According to the company, Shi will coordinate execution across all subsidiaries and align regional campaigns with spring planting timelines.

What operational changes did Origin Agritech make to support Aoyun 2026 (SEED)?

Origin rebuilt its commercial organization, expanding the sales team and completing leadership restructuring. According to the company, the firm increased sales staff from 63 to 106 and secured a Beijing seed production license to support 2026 rollout.

How do the 2026–2027 performance contracts impact Origin Agritech (SEED)?

The contracts formalize operational and financial targets across subsidiaries and management. According to the company, CEO and vice presidents signed agreements to establish clear accountability chains for converting rebuilt infrastructure into measurable commercial results.

How does Aoyun 2026 align with China's 2026 planting season for SEED products?

The regional rollout timing is set to match China's spring planting season beginning after Jingzhe on March 5, 2026. According to the company, deployment plans span primary corn belts to optimize adoption during the planting window.